Update on cellular transplantation into the CNS as a novel therapy for chronic pain

KA Czech, J Sagen - Progress in neurobiology, 1995 - Elsevier
The transplantation of cells that secrete neuroactive substances with analgesic properties
into the CNS is a novel method that challenges current approaches in treating chronic pain. …

Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury

ES Fu, YP Zhang, J Sagen, KA Candiotti, PD Morton… - PAIN®, 2010 - Elsevier
The transcription factor nuclear factor kappa B (NF-κB) is a key regulator of inflammatory
processes in reactive glial cells. We utilized a transgenic mouse model (GFAP-IκBα-dn) where …

Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis

U Herzberg, J Sagen - Journal of neuroimmunology, 2001 - Elsevier
Painful sensory neuropathy is a common and debilitating consequence of human
immunodeficiency virus (HIV). The underlying causes of neuropathic pain are most likely not due to …

Widespread cellular proliferation and focal neurogenesis after traumatic brain injury in the rat

C Urrea, DA Castellanos, J Sagen… - Restorative …, 2007 - content.iospress.com
Purpose: A proliferation of stem/progenitor cells is observed after brain injury. We examined
the regional and temporal profile of mitotically active cells to determine whether traumatic …

Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances

J Sagen, H Wang, PA Tresco… - Journal of …, 1993 - Soc Neuroscience
Adrenal medullary chromaffin cells are a potential source of neuroactive substances for
transplantation into the CNS to alleviate neurochemical deficits. In particular, work in our …

Mutually beneficial effects of intensive exercise and GABAergic neural progenitor cell transplants in reducing neuropathic pain and spinal pathology in rats with spinal …

EA Dugan, S Jergova, J Sagen - Experimental neurology, 2020 - Elsevier
Spinal cord injury (SCI) produces both locomotor deficits and sensory dysfunction that greatly
reduce the overall quality of life. Mechanisms underlying chronic pain include increased …

[HTML][HTML] Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model

A Eeswara, A Pacheco-Spiewak, S Jergova, J Sagen - PloS one, 2023 - journals.plos.org
The most frequently reported use of medical marijuana is for pain relief. However, its
psychoactive component Δ9-tetrahydrocannabinol (THC) causes significant side effects. …

Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain

A Hama, J Sagen - Journal of neurotrauma, 2011 - liebertpub.com
Symptoms of neuropathic spinal cord injury (SCI) pain include cutaneous hypersensitivity
and spontaneous pain below the level of the injury. Riluzole, an FDA-approved drug for the …

Effect of intrathecally administered noradrenergic antagonists on nociception in the rat

J Sagen, HK Proudfit - Brain research, 1984 - Elsevier
Recent evidence suggests that some groups of noradrenergic neurons found in the brainstem
have axonal connections in the spinal cord dorsal horn and may be involved in the control …

Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain

AT Hama, J Sagen - Neuropharmacology, 2010 - Elsevier
Pre-clinical evidence demonstrates that neuropathic spinal cord injury (SCI) pain is maintained
by a number of neurobiological mechanisms, suggesting that treatments directed at …